Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 1 of the 19 sources its claims cite were checked for support.
Abstract
To determine the plasma epinephrine thresholds for its metabolic and hemodynamic actions and plasma epinephrine metabolic clearance rates, 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 microgram/min were performed in each of six normal human subjects. These 30 infusions resulted in steady-state plasma epinephrine concentrations ranging from 24 to 1,020 pg/ml. Plasma epinephrine thresholds were 50-100 pg/ml for increments in heart rate, 75-125 pg/ml for increments in blood glycerol and systolic blood pressure, 150-200 pg/ml for increments in plasma glucose (the resultant of increments in glucose production and decrements in glucose clearance), blood lactate, blood beta-hydroxybutyrate, and diastolic blood pressure, and greater than 400 pg/ml for early decrements in plasma insulin. Changes in blood alanine, plasma glucagon, plasma growth hormone, and plasma cortisol were not detected. At steady-state plasma epinephrine concentrations of 24-74 pg/ml, values overlapping the basal normal range, the mean (+/-SE) plasma metabolic clearance rate of epinephrine was 52 +/- 4 ml x min-1 x kg-1; this value rose to 89 +/- 6 ml x min-1 x kg-1 (P less than 0.01) at steady-state epinephrine concentrations of 90-1,020 pg/ml. We conclude that in human subjects: (a) the plasma epinephrine thresholds for its hemodynamic and metabolic actions lie within the physiologic range, (b) epinephrine and norepinephrine accelerate their own metabolic clearance, and (c) epinephrine is 10 times more potent than norepinephrine.
Overview
CoChat Summary
TL;DR
In six normal human subjects, graded epinephrine infusions showed that hemodynamic and metabolic thresholds occur within the physiologic plasma epinephrine range. The study also found that epinephrine accelerates its own metabolic clearance and is about 10 times more potent than norepinephrine.
Key findings
- Across 30 infusions, steady-state plasma epinephrine concentrations ranged from 24 to 1,020 pg/ml. Thresholds were 50–100 pg/ml for heart-rate increments; 75–125 pg/ml for systolic blood pressure and blood glycerol increments; 150–200 pg/ml for plasma glucose, glucose production, glucose clearance, blood lactate, blood β-hydroxybutyrate, and diastolic blood pressure changes; and >400 pg/ml for early plasma insulin decrements. No significant changes were detected in blood alanine, plasma glucagon, growth hormone, or cortisol.
- Plasma epinephrine metabolic clearance rate was 52±4 ml·min⁻¹·kg⁻¹ at steady-state epinephrine concentrations of 24–74 pg/ml, overlapping the basal normal range, and rose to 89±6 ml·min⁻¹·kg⁻¹ at 90–1,020 pg/ml (P < 0.01), an approximately 70% increase.
- From earlier norepinephrine data, plasma norepinephrine metabolic clearance rate was 25±4 ml·min⁻¹·kg⁻¹ at 229–345 pg/ml and 39±3 ml·min⁻¹·kg⁻¹ at higher levels (P < 0.02), suggesting catecholamines accelerate their own clearance.
- Epinephrine thresholds for direct metabolic and hemodynamic effects (<200 pg/ml) were about 10% of previously determined norepinephrine thresholds (1,500–2,000 pg/ml), indicating epinephrine is ~10-fold more potent.
Methods
- Six normal subjects (five men, one woman) each received five 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 μg/min after an overnight fast, supine, with infusions separated by at least 1 wk.
- Plasma epinephrine and norepinephrine were measured by a single isotope derivative method; glucose by glucose oxidase; insulin, glucagon, and growth hormone by radioimmunoassay; cortisol by competitive protein binding; lactate, alanine, β-hydroxybutyrate, and glycerol by microfluorometric enzymatic techniques. Glucose kinetics used a primed continuous infusion of [6,6-²H₂]glucose with Steele’s equations for nonsteady-state conditions.
- Plasma epinephrine metabolic clearance rate was calculated as measured infusion rate divided by the difference between steady-state and basal plasma epinephrine. Thresholds were estimated by inspection of semilogarithmic plots, extending regression lines through changed data points to the line of no change, and tended to be confirmed by nonlinear least squares regression.
Limitations
- The paper states that the metabolic clearance calculation assumes basal endogenous epinephrine release continues during infusion; if endogenous release ceases, the calculation overestimates clearance, especially at lower steady-state concentrations. It also states that extremity epinephrine uptake may cause overestimation of epinephrine clearance and underestimation of norepinephrine clearance.
- The paper states that threshold estimates were obtained by inspection and extrapolation of the central linear portion of sigmoidal dose-response curves, providing a maximum estimate; nonlinear least squares regression tended to confirm these values.
- Evident from the text: the sample was small (six normal subjects, five men and one woman), and the study examined only normal human subjects, so findings may not generalize to women, other populations, or pathophysiologic states. The authors also note one discrepancy with earlier studies: they did not observe an increase in plasma glucagon during epinephrine infusions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 10 Not checked · 36 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As noted earlier, plasma epinephrine concentrations of this magnitude do occur during heavy exercise and absolute hypoglycemia, as well as during a variety of acute illnesses.”
What the sources say
- Not checked — no full text of the sourcecites [27] Galbo, H., J. J. Holst, and N. J. Christensen. 1975. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. J. Appl. Physiol. 38: 70–76. source
- Partly supportedcites [28] Garber, A. J., P. E. Cryer, J. V. Santiago, M. W. Haymond, A. S. Pagliara, and D. M. Kipnis. 1976. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 58: 7-15. sourceExperimental — accuracy not yet measured
Our copy supports only the hypoglycemia limb of the claim: RESULTS p. 4 reports mean plasma epinephrine rising from 43±2 pg/ml to maximal levels of 2,200±660 pg/ml (50× basal) during insulin-induced hypoglycemia (plasma glucose 89±3 → 39±2 mg/dl, INTRODUCTION p. 1), i.e. concentrations far above 400 pg/ml in absolute hypoglycemia. The exercise and acute-illness limbs are not in our copy — METHODS p. 2 states subjects were maintained on absolute bed rest, and no passage reports epinephrine during heavy exercise or during acute illness; the DISCUSSION (p. 6) instead closes by saying a role for adrenergic mechanisms in 'more physiologic fluctuations' of plasma glucose 'remains to be established.' Searched: exercise/physical exertion, acute illness/stress, epinephrine >400 pg/ml. (LLM, conf=0.75)
- Not matchedcites [30]
The reference list we hold has no entry [30].
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose clearance declined and remained suppressed during the infusion of epinephrine at the higher infusion rates”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose utilization did not change”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but lower for increments in blood glycerol, 75–125 pg/ml”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
In the paper
“As noted previously (25), glucose production rose transiently, returning to near base line by 60 min”
What the sources say
- Not checked — no full text of the sourcecites [25] Rizza, R. A., M. W. Haymond, P. E. Cryer, and J. E. Gerich. 1979. Differential effects of physiologic concentrations of epinephrine on glucose production and disposal in man. Am. J. Physiol. 237: E356–E362. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 47 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“plasma epinephrine concentrations do not commonly achieve the threshold level required to affect basal glucose metabolism (7).”
From Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion (1983) · cites this paper as [7]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a more than eightfold increase in mean plasma epinephrine to a level known to have hyperglycemic effects in man (38).”
From Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man (1984) · cites this paper as [38]
Citations
Cites
Effect of Ischemia on Known Substrates and Cofactors of the Glycolytic Pathway in Brain
Lowry, O. H., Passonneau, J. V., Hasselberger, F. X., & Schulz, D. W. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51740-3 · Cited by 2,221
Cryer, P. E., Haymond, M. W., Santiago, J. V., & Shah, S. D. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609092951101 · Cited by 1,101
Self-citationHormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma
SCHALCH, D. S., & PARKER, M. L. (1964) · Nature · doi:10.1038/2031141a0 · Cited by 635
Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose
Bier, D. M., Leake, R. D., Haymond, M. W., Arnold, K. J., Gruenke, L. D., Sperling, M. A., & Kipnis, D. M. (1977) · Diabetes · doi:10.2337/diab.26.11.1016 · Cited by 444
Self-citationGlucagon and plasma catecholamine responses to graded and prolonged exercise in man
Galbo, H., Holst, J. J., & Christensen, N. J. (1975) · Journal of Applied Physiology · doi:10.1152/jappl.1975.38.1.70 · Cited by 406
Immunoassay of Insulin Using a Two-Antibody System.
Morgan, C. R., & Lazarow, A. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-110-27411 · Cited by 367
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citationDetermination of norepinephrine apparent release rate and clearance in humans
Esler, M., Jackman, G., Bobik, A., Kelleher, D., Jennings, G., Leonard, P., Skews, H., & Korner, P. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90371-0 · Cited by 344
Cited by
Items 101–200 of 577
Pharmacokinetics of Cardiovascular Drugs in Children: Inotropes and Vasopressors
Steinberg, C., & Notterman, D. A. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427050-00003 · Cited by 84
Tse, T. F., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110967 · Cited by 73
Self-citationEpinephrine and the metabolic syndrome
Ziegler, M. G., Elayan, H., Milic, M., Sun, P., & Gharaibeh, M. (2012) · Current Hypertension Reports · doi:10.1007/s11906-011-0243-6 · Cited by 75
Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs
Cherrington, A. D., Fuchs, H., Stevenson, R. W., Williams, P. E., Alberti, K. G., & Steiner, K. E. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e137 · Cited by 75
Perioperative Management of the Diabetic Patient
Gavin, L. A. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30226-3 · Cited by 73
Effects of epinephrine on regional free fatty acid and energy metabolism in men and women
Jensen, M. D., Cryer, P. E., Johnson, C. M., & Murray, M. J. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e259 · Cited by 74
Self-citationAdrenergic Blockade Reduces Skeletal Muscle Glycolysis and Na+, K+-ATPase Activity during Hemorrhage
McCarter, F. D., James, J. H., Luchette, F. A., Wang, L., Friend, L. A., King, J.-K., Evans, J. M., George, M. A., & Fischer, J. E. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6175 · Cited by 77
“under well-oxygenated conditions [4, 5].”
Diabetes and behavior: A paradigm for health psychology.
Surwit, R. S., Feinglos, M. N., & Scovern, A. W. (1983) · American Psychologist · doi:10.1037//0003-066x.38.3.255 · Cited by 83
Samra, J. S., Summers, L. K. M., & Frayn, K. N. (1996) · British journal of surgery · doi:10.1046/j.1365-2168.1996.02445.x · Cited by 94
Concentration effect relationships of infused histamine in normal volunteers
Ind, P. W., Brown, M. J., Lhoste, F., Macquin, I., & Dollery, C. T. (1982) · Inflammation Research · doi:10.1007/bf01965099 · Cited by 72
Burge, M. R. (1998) · JAMA · doi:10.1001/jama.279.2.137 · Cited by 71
Lane, S., Maender, K. C., AWENDER, N. E., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9802031 · Cited by 72
“These infusion rates were selected using data of Clutter and coworkers (17) who found that a linear relationship existed between the epinephrine infusion rate and steady-state plasma epinephrine concentration in humans and that at a given infusion rate, plasma epinephrine concentration remained constant once steady-st…”
MethodEffects of Glycemic Control on Protective Responses Against Hypoglycemia in Type 2 Diabetes
Korzon-Burakowska, A., Hopkins, D., Matyka, K., Lomas, J., Pernet, A., Macdonald, I., & Amiel, S. (1998) · Diabetes Care · doi:10.2337/diacare.21.2.283 · Cited by 71
“33 pmol/l for norepinephrine, >192 nmol/1 for cortisol, and > 18 mU/1 for growth hormone (26,27).”
Treating Critical Illness: The Importance of First Doing No Harm
Singer, M., & Glynne, P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020167 · Cited by 76
The stressful condition as a nutritionally dependent adaptive dichotomy
Ingenbleek, Y., & Bernstein, L. H. (1999) · Nutrition · doi:10.1016/s0899-9007(99)00009-x · Cited by 80
Effects of Anesthetics Containing Epinephrine on Catecholamine Levels During Periodontal Surgery
Davenport, R. E., Porcelli, R. J., Iacono, V. J., et al. (1990) · Journal of Periodontology · doi:10.1902/jop.1990.61.9.553 · Cited by 71
Vasoconstrictors in local anesthesia for dentistry.
Sisk, A. L. (1992) · PubMed · Cited by 70
Electrophysiologic effects of epinephrine in humans
Morady, F., Nelson, S. D., Kou, W. H., Pratley, R. E., Schmaltz, S. P., de Buitleir, M., & Halter, J. B. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90287-2 · Cited by 70
Thompson, J. P., Boyle, J. R., THOMPSON, M. M., Strupish, J. W., BELL, P. R. F., & Smith, G. (1999) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.1998.0760 · Cited by 66
Tse, T. F., Clutter, W. E., Shah, S. D., Miller, J. P., & Cryer, P. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110966 · Cited by 68
Self-citationThe effect of acute, chronic, and prenatal ethanol exposure on insulin sensitivity
Ting, J. W., & Lautt, W. W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.004 · Cited by 72
Diamond, M. P., Reece, E. A., Caprio, S., Jones, T. W., Amiel, S., DeGennaro, N., Laudano, A., Addabbo, M., Sherwin, R. S., & Tamborlane, W. V. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91832-u · Cited by 66
Sung, J. J. �., Chung, S. C. S., Low, J. M., et al. (1993) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(93)70004-8 · Cited by 67
The hemodynamic and plasma catecholamine responses to routine restorative dental care
Cioffi, G. A., Chernow, B., Glahn, R. P., et al. (1985) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1985.0038 · Cited by 66
SALONEN, M. A. O., Forssell, H., & Scheinin, M. (1988) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0901-5027(88)80071-7 · Cited by 66
Metabolic and Cardiovascular Responses to Epinephrine in Diabetic Autonomic Neuropathy
Hilsted, J., Richter, E., Madsbad, S., Tronier, B., Christensen, N. J., Hildebrandt, P., Damkjær, M., & Galbo, H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170705 · Cited by 65
This and That: on color and catecholamines
Max, B. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90078-3 · Cited by 65
Minifee, P. K., Barrow, R. E., Abston, S., et al. (1989) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(89)80541-x · Cited by 63
Coronary artery spasm induced by intravenous epinephrine overdose
Karch, S. B. (1989) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(89)90250-7 · Cited by 63
Hoelzer, D. R., Dalsky, G. P., Clutter, W. E., Shah, S. D., Holloszy, J. O., & Cryer, P. E. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112279 · Cited by 62
Self-citationRetractedMendenhall, L. A., Swanson, S. C., Habash, D. L., & Coggan, A. R. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.1.e136 · Cited by 63
Gustavson, S. M., Chu, C. A., Nishizawa, M., Farmer, B., Neal, D. W., Yang, Y., Donahue, E. P., Flakoll, P. J., & Cherrington, A. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00308.2002 · Cited by 64
“Lactate levels rose markedly with epinephrine treatment, as shown previously (6, 10, 14, 59), presumably due to increased lactate production from muscle glycogenolysis.”
BackgroundAging and Marrow Neutrophil Reserves
Chatta, G. S., Price, T. H., Stratton, J. R., & Dale, D. C. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06077.x · Cited by 60
Troullos, E. S., Goldstein, D. S., Km, H., & Ra, D. (1987) · PubMed Central · Cited by 62
Isotope ratio measurements in nutrition and biomedical research
Hachey, D. L., Wong, W. W., Boutton, T. W., & Klein, P. (1987) · Mass Spectrometry Reviews · doi:10.1002/mas.1280060203 · Cited by 70
Catecholamine and blood lactate responses to incremental rowing and running exercise
WELTMAN, A. L., Wood, C. M., Womack, C. J., Davis, S. E., Blumer, J. L., Álvarez, J., Sauer, K., & Gaesser, G. A. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.3.1144 · Cited by 62
Physiological increments in epinephrine stimulate metabolic rate in humans
Staten, M. A., Matthews, D. E., Cryer, P. E., & Bier, D. M. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.253.3.e322 · Cited by 61
Self-citationElevated plasma noradrenaline in response to beta‐adrenoceptor stimulation in man.
Hh, V., Veld, M. I. A., Boomsma, F., Wenting, G. J., & Schalekamp, M. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb01442.x · Cited by 67
Knoll-Köhler, E., Knöller, M., Brandt, K., & Becker, J. (1991) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(91)90059-u · Cited by 56
Does Psychological Stress Cause Diabetes?
Wales, J. K. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00439.x · Cited by 59
Plasma catecholamine and blood lactate responses to incremental arm and leg exercise
Schneider, D. A., McLellan, T. M., & Gass, G. C. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200003000-00009 · Cited by 75
“These Epi concentrations agree with those reported to produce a rise in blood [La] during Epi infusion at rest (6,20,23).”
BackgroundResultIntravenous cocaine increases plasma epinephrine and norepinephrine in humans
Sofuoglu, M., Nelson, D. B., Babb, D. A., & Hatsukami, D. K. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00482-8 · Cited by 62
Bravo, E. L., & Gifford, R. W. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30169-5 · Cited by 71
Morady, F., Kou, W. H., Kadish, A. H., et al. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90411-1 · Cited by 58
Effects of short-term oral salbutamol administration on exercise endurance and metabolism
Collomp, K., Candau, R. B., Lasne, F., Labsy, Z., Prefaut, C., & de Ceaurriz, J. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.430 · Cited by 58
“Furthermore, given the well-known direct or indirect involvement of b2-adrenoceptors in different metabolic pathways (4, 13, 23, 25, 30), hormonal and/or metabolic effects resulting from Sal intake may be expected to have an influence on exercise endurance.”
BackgroundBeckmann, S. L., Ingrid, O. S., Kjeldsen, S. E., Eide, I. K., Westheim, A. S., & Hjermann, I. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00122-6 · Cited by 57
Kreisman, S. H., Halter, J. B., Vranic, M., & Marliss, E. B. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1347 · Cited by 56
The Use of Vasopressors and Inotropes in the Emergency Medical Treatment of Shock
Ellender, T. J., & Skinner, J. C. (2008) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2008.04.001 · Cited by 61
Cardiovascular and metabolic responses to submaximal exercise in hemodialysis patients
Kettner, A., Goldberg, A., Hagberg, J. M., Delmez, J. A., & Harter, H. R. (1984) · Kidney International · doi:10.1038/ki.1984.135 · Cited by 56
Effect of Circulating Epinephrine on Platelet Function and Hematocrit
Kjeldsen, S. E., Weder, A. B., Egan, B. M., Neubig, R. R., Zweifler, A. J., & Julius, S. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1096 · Cited by 56
Kennedy, B., Bigby, T. D., & Ziegler, M. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117996 · Cited by 55
Takolander, R., Bergqvist, D., Hulthén, U. L., et al. (1990) · European Journal of Vascular Surgery · doi:10.1016/s0950-821x(05)80205-1 · Cited by 55
Boyle, P. J., Avogaro, A., Smith, L., Bier, D. M., Pappu, A. S., Illingworth, D. R., & Cryer, P. E. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.1.e168 · Cited by 55
Self-citationEffects of epinephrine infusion on leucine and alanine kinetics in humans
Miles, J. M., Nissen, S., Gerich, J. E., & Haymond, M. W. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e166 · Cited by 65
Pascoe, P. J., Ilkiw, J. E., & Fisher, L. D. (1997) · American Journal of Veterinary Research · doi:10.2460/ajvr.1997.58.11.1267 · Cited by 54
The neuroendocrine response to multiple trauma
Gann, D. S., & Lilly, M. P. (1983) · World Journal of Surgery · doi:10.1007/bf01655918 · Cited by 55
Majerus, T. C., Dasta, J. F., Bauman, J. L., Danziger, L. H., & Ruffolo, R. R., Jr. (1989) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1989.tb04133.x · Cited by 51
Catecholamine-induced hypertensive crises: current insights and management
Nazari, M. A., HASAN, M. R., Haigney, M. C., Maghsoudi, A., Lenders, J. W. M., Carey, R. M., & Pacák, K. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00256-5 · Cited by 65
Mezzacappa, E. S., Kelsey, R. M., & Katkin, E. S. (1999) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(98)00058-0 · Cited by 60
Darbar, D., Smith, M., Mörike, K., & Roden, D. M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00204-4 · Cited by 52
Alternating lateralization of plasma catecholamines and nasal patency in humans
Kennedy, B. P., Ziegler, M. G., & Shannahoff‐Khalsa, D. S. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90175-x · Cited by 53
Nuutila, P., Peltoniemi, P., Oikonen, V, Larmola, K., Kemppainen, J., Takala, T., Sipilä, H., Oksanen, A., Ruotsalainen, U., Bolli, G. B., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1084 · Cited by 53
“Plasma adrenaline concentrations increased slightly during the exercise periods, but the increases were quantitatively trivial (49) with no significant differences between the groups.”
BackgroundCircadian Variation in Adrenergic Responses in Asthmatic Subjects
Barnes, P. J., FitzGerald, G. A., & Dollery, C. T. (1982) · Clinical Science · doi:10.1042/cs0620349 · Cited by 53
In Vivo Evidence That Endogenous Dopamine Modulates Sympathetic Activity in Man
Mannelli, M., Ianni, L., Lazzeri, C., Castellani, W., Pupilli, C., Villa, G. L., Barletta, G., Serio, M., & Franchi, F. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.398 · Cited by 52
Kerr, D., MacDonald, I., Heller, Sr., & Tattersall, R. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03689.x · Cited by 52
Thresholds for physiological effects of plasma catecholamines in fetal sheep
Padbury, J. F., Ludlow, J. K., Ervin, M. G., Jacobs, H. C., & Humme, J. A. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.4.e530 · Cited by 60
Hughes, G. S. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90523-x · Cited by 51
Adrenergic Antagonists Reduce Lactic Acidosis in Response to Hemorrhagic Shock
Luchette, F. A., Robinson, B. R. H., Friend, L. A., McCarter, F. D., Frame, S. B., & James, J. H. (1999) · doi:10.1097/00005373-199905000-00017 · Cited by 49
Bao, X., Lu, C. M., Liu, F., Gu, Y., Dalton, N. D., Zhu, B., Foster, E., Chen, J., Karliner, J. S., ROSS, J. R., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.696005 · Cited by 59
“where EDV is end-diastolic volume and ESV is end-systolic volume, and ( 3 ) COHRSV.”
BackgroundBravo, E. L. (2002) · Cardiology in Review · doi:10.1097/00045415-200201000-00009 · Cited by 48
Blankestijn, P., Tulen, J. H. M., Boomsma, F., van Eck, H. J. R., Mulder, P. G. M., VELD, A. M. I., van den Meiracker, A. H., Moleman, P., Derkx, F. M., Lamberts, S., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90585-5 · Cited by 51
Epinephrine infusion during moderate intensity exercise increases glucose production and uptake
Kreisman, S. H., Mew, N. A., Arsenault, M., Nessim, S. J., Halter, J. B., Vranic, M., & Marliss, E. B. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e949 · Cited by 48
“Although some (5, 30) produced Epi levels comparable to those of IE, the 1.”
ResultSechen, S. J., McCutcheon, S. N., & Bauman, D. E. (1989) · Domestic Animal Endocrinology · doi:10.1016/0739-7240(89)90043-x · Cited by 48
Pharmacokinetics of dopamine in critically ill newborn infants
Padbury, J. F., Agata, Y., Baylen, B. G., Ludlow, J. K., Polk, D. H., Habib, D. M., & Martinez, A. M. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81101-1 · Cited by 45
Epinephrine infusions in patients with social phobia
Papp, L. A., Gorman, J. M., Liebowitz, M. R., Fyer, A. J., Cohen, B. S., & Klein, D. F. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.6.733 · Cited by 47
Epinephrine produces a prolonged elevation in metabolic rate in humans
Ratheiser, K., Brillon, D. J., Campbell, R. G., & Matthews, D. E. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.5.1046 · Cited by 50
Abboud, I., Lerolle, N., Urien, S., Tadié, J., Leviel, F., Fagon, J.-Y., & Faisy, C. (2009) · Critical Care · doi:10.1186/cc7972 · Cited by 54
“In our study, basal endogenous epinephrine concentrations were higher than those of resting healthy adults [21,27-29] but lower than those found in a previous population of patients with septic shock [30].”
BackgroundResultThe neuroendocrinology of physical injury
Barton, R. N. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80067-8 · Cited by 46
Jie, K., van Brummelen, P., Vermey, P., Timmermans, P. B. M. W. M., & van Zwieten, P. A. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb02397.x · Cited by 46
Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus
Campbell, P. J., Bolli, G. B., Cryer, P. E., & Gerich, J. E. (1985) · Metabolism · doi:10.1016/0026-0495(85)90153-2 · Cited by 45
Self-citationGoldberger, J. J., Ahmed, M. W., Parker, M. A., et al. (1994) · Circulation · doi:10.1161/01.cir.89.4.1656 · Cited by 45
The effect of caffeine on glucose kinetics in humans - influence of adrenaline
Battram, D. S., Graham, T. E., Richter, E. A., & Dela, F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.097444 · Cited by 44
“In addition, a caffeine-induced increase in sympathetic activity may stimulate EGP (Clutter et al. 1980; Galster et al. 1981; Sacca et al. 1983).”
BackgroundMethodInfluentialMechanisms of catecholamine effects on ketogenesis
Bahnsen, M. K., Burrin, J. M., Johnston, D. G., Pernet, A., Walker, M., & Alberti, K. G. M. M. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e173 · Cited by 42
Direct alpha-adrenergic stimulation of hepatic glucose production in human subjects
Rosen, S. G., Clutter, W. E., Shah, S. D., Miller, J. P., Bier, D. M., & Cryer, P. E. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.245.6.e616 · Cited by 43
Self-citationPsychophysiological responses to dental injections
Fiset, L. O., Milgrom, P., Weinstein, P., Getz, T., & Glassman, P. (1985) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1985.0160 · Cited by 48
Prevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes
Cryer, P. E. (2003) · Type 1 Diabetes · doi:10.1007/978-1-59259-310-1_7 · Cited by 42
Self-citationMaintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?
Raju, B., & Cryer, P. E. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00460.2004 · Cited by 42
“Plasma epinephrine concentrations increased slightly, but not to biologically effective concentrations (6), after intravenous but not after oral diazoxide.”
BackgroundSelf-citationVasoconstrictors and the Heart
Pallasch, T. J. (1998) · Journal of the California Dental Association · doi:10.1080/19424396.1998.12221721 · Cited by 42
Epinephrine: systemic effects and varying concentrations in local anesthesia.
Cassidy, J., Phero, J. C., & Grau, W. H. (1987) · PubMed · Cited by 42
Rosen, S. G., Clutter, W. E., Berk, M. A., Shah, S. D., & Cryer, P. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111226 · Cited by 41
Self-citationTanimoto, S., Kaliner, M., Lockey, R. F., et al. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.10.024 · Cited by 41
PHARMACOLOGY OF PEDIATRIC RESUSCITATION
Ushay, H. M., & Notterman, D. A. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70470-3 · Cited by 41
Flavahan, N. A., Grant, T. L., Greig, J., et al. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb09458.x · Cited by 41
Thermogenesis after a mixed meal: role of leg and splanchnic tissues in men and women
Jensen, M. D., Johnson, C. M., Cryer, P. E., & Murray, M. J. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.3.e433 · Cited by 39
Self-citationCryer, P. E., Tse, T. F., Clutter, W. E., & SHAH, S. D. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e198 · Cited by 47
Self-citationPharmacokinetic and Pharmacodynamic Considerations in Drug Therapy of Cardiac Emergencies
Pentel, P. R., & Benowitz, N. L. (1984) · Clinical Pharmacokinetics · doi:10.2165/00003088-198409040-00001 · Cited by 40
Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation.
Attvall, S., Eriksson, B. M., Fowelin, J., von Schenck, H., Lager, I., & Smith, U. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113091 · Cited by 40
Jensen, J., Ruge, T., Lai, Y., Svensson, M. K. E., & Eriksson, J. W. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.028 · Cited by 39
“1 nmol/L for effect on blood glucose and lactate [3,57,58].”
BackgroundMethodResultPlasma and urinary catecholamines as related to renal function in man
Laederach, K., & Weidmann, P. U. (1987) · Kidney International · doi:10.1038/ki.1987.16 · Cited by 38
Kjeldsen, S. E., Schork, N. J., Leren, P., & Eide, I. K. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90592-9 · Cited by 38
Metadata
- Authors
- Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Bier, D M
- Venue
- Journal of Clinical Investigation
- Published
- 1980-07-01
- Volume
- 66
- Issue
- 1
- Pages
- 94-101
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371510
- OpenAlex
- W2133884882
- Cited by
- 576
- References
- 31
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- epinephrine, norepinephrine, heart rate, blood pressure, blood glucose, blood lactate, beta-hydroxybutyrate, insulin, hemodynamic effects, metabolic effects, dose-response relationship
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Dose-Response Relationship, Drug, Epinephrine, Female, Glucagon, Heart Rate, Humans, Insulin, Kinetics, Male, Metabolic Clearance Rate, Norepinephrine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.